(Q40817191)

24 September 2017

title

Cell cycle and biochemical effects of PD 0183812. A potent inhibitor of the cyclin D-dependent kinases CDK4 and CDK6. (English)

1 reference

24 September 2017

Fry DW

1

1 reference

24 September 2017

Bedford DC

2

1 reference

24 September 2017

Harvey PH

3

1 reference

24 September 2017

Fritsch A

4

1 reference

24 September 2017

Keller PR

5

1 reference

24 September 2017

Wu Z

6

1 reference

24 September 2017

Dobrusin E

7

1 reference

24 September 2017

Leopold WR

8

1 reference

24 September 2017

Fattaey A

9

1 reference

24 September 2017

Garrett MD

10

1 reference

24 September 2017

language of work or name

English

0 references

publication date

6 February 2001

1 reference

Journal of Biological Chemistry

24 September 2017

published in

1 reference

24 September 2017

volume

276

1 reference

24 September 2017

issue

20

1 reference

24 September 2017

page(s)

16617-16623

1 reference

Cyclin-dependent kinases: engines, clocks, and microprocessors

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Induction of S phase by G1 regulatory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Multiple ras effector pathways contribute to G(1) cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Wnt1 and MEK1 cooperate to promote cyclin D1 accumulation and cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Role of the retinoblastoma protein in the pathogenesis of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Cyclin D1 and human neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

The INK4A/ARF locus and its two gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Growth suppression by p16ink4 requires functional retinoblastoma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Pyrido[2,3-d]pyrimidin-7-one inhibitors of cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Identification of G1 kinase activity for cdk6, a novel cyclin D partner

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Biochemical and antiproliferative properties of 4-[ar(alk)ylamino]pyridopyrimidines, a new chemical class of potent and specific epidermal growth factor receptor tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

A reversible arrest point in the late G1 phase of the mammalian cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

D-type cyclin-dependent kinase activity in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Apoptosis in interleukin-3-dependent haemopoietic cells. Quantification by two flow cytometric methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

A cyclin D-Cdk4 activity required for G2 phase cell cycle progression is inhibited in ultraviolet radiation-induced G2 phase delay

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Anticancer drug targets: cell cycle and checkpoint control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

p16(INK4a) and the control of cellular proliferative life span.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Chemical inhibitors of cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Identification of cytosolic aldehyde dehydrogenase 1 from non-small cell lung carcinomas as a flavopiridol-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Characterization of novel inhibitors of cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Inhibition of cyclin-dependent kinase 4 (Cdk4) by fascaplysin, a marine natural product

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M008867200

21 January 2018

Identifiers

DOI

10.1074/JBC.M008867200

1 reference

release_gvotszaaozaubkio4kinuj23oy

24 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gvotszaaozaubkio4kinuj23oy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference